In today’s recent session, 39.76 million shares of the Mira Pharmaceuticals Inc (NASDAQ:MIRA) have been traded, and its beta is 2.10. Most recently the company’s share price was $1.04, and it changed around $0.14 or 15.92% from the last close, which brings the market valuation of the company to $17.48M. MIRA at last check was trading at a discount to its 52-week high of $5.01, offering almost -381.73% off that amount. The share price’s 52-week low was $0.51, which indicates that the recent value has risen by an impressive 50.96% since then. We note from Mira Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.12 million shares, with the 3-month average coming to 253.70K.
Mira Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended MIRA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Mira Pharmaceuticals Inc is expected to report earnings per share of -0.14 for the current quarter.
Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information
Instantly MIRA has been showing a green trend so far today with a performance of 15.92% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.3300 on recent trading dayincreased the stock’s daily price by 21.8%. The company’s shares are currently down -8.77% year-to-date, but still up 23.08% over the last five days. On the other hand, Mira Pharmaceuticals Inc (NASDAQ:MIRA) is -11.11% down in the 30-day period. We can see from the shorts that 0.57 million shares have been sold at a short interest cover period of 1.57 day(s).
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -224.25%.
MIRA Dividends
Mira Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2025-Mar-27.
Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 23.33% of Mira Pharmaceuticals Inc shares, and 6.51% of them are in the hands of institutional investors. The stock currently has a share float of 8.49%.
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 117.82 shares worth $0.12 million, making up 0.70% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 58.24 shares worth around $61733.0, which represents about 0.35% of the total shares outstanding.
